Pfister D - Search Results

1

Salvage re-irradiation for recurrent head and neck cancer.

Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, Wolden S, Venkatraman ES, Pfister D, Kraus D, Shah J, Zelefsky MJ. Lee N, et al. Among authors: pfister d. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):731-40. doi: 10.1016/j.ijrobp.2006.12.055. Epub 2007 Mar 26. Int J Radiat Oncol Biol Phys. 2007. PMID: 17379449 Clinical Trial.

2

Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome.

Harrison LB, Zelefsky MJ, Sessions RB, Fass DE, Armstrong JG, Pfister DG, Strong EW. Harrison LB, et al. Among authors: pfister dg. Radiology. 1992 Jul;184(1):267-70. doi: 10.1148/radiology.184.1.1609090. Radiology. 1992. PMID: 1609090

3

Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer.

Harrison LB, Pfister DG, Fass DE, Armstrong JG, Sessions RB, Shah JP, Spiro RH, Strong EW, Weisen S, Bosl GJ. Harrison LB, et al. Among authors: pfister dg. Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):703-8. doi: 10.1016/0360-3016(91)90689-2. Int J Radiat Oncol Biol Phys. 1991. PMID: 1869464

4

Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.

Pfister DG, Strong E, Harrison L, Haines IE, Pfister DA, Sessions R, Spiro R, Shah J, Gerold F, McLure T, et al. Pfister DG, et al. Among authors: pfister da. J Clin Oncol. 1991 May;9(5):850-9. doi: 10.1200/JCO.1991.9.5.850. J Clin Oncol. 1991. PMID: 2016629

5

Salvage laryngectomy for unsuccessful larynx preservation therapy.

Kraus DH, Pfister DG, Harrison LB, Spiro RH, Strong EW, Zelefsky M, Bosl GJ, Shah JP. Kraus DH, et al. Among authors: pfister dg. Ann Otol Rhinol Laryngol. 1995 Dec;104(12):936-41. doi: 10.1177/000348949510401204. Ann Otol Rhinol Laryngol. 1995. PMID: 7492064

6

Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer.

Tavorath R, Pfister DG. Tavorath R, et al. Among authors: pfister dg. Curr Opin Oncol. 1995 May;7(3):242-7. doi: 10.1097/00001622-199505000-00009. Curr Opin Oncol. 1995. PMID: 7654826 Review.

7

Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation.

Pfister DG, Harrison LB, Strong EW, Shah JP, Spiro RW, Kraus DH, Armstrong JG, Zelefsky MJ, Fass DE, Weiss MH, et al. Pfister DG, et al. J Clin Oncol. 1995 Mar;13(3):671-80. doi: 10.1200/JCO.1995.13.3.671. J Clin Oncol. 1995. PMID: 7884428 Clinical Trial.

8

Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer.

Kraus DH, Pfister DG, Harrison LB, Shah JP, Spiro RH, Armstrong JG, Fass DE, Zelefsky M, Schantz SP, Weiss MH, et al. Kraus DH, et al. Among authors: pfister dg. Otolaryngol Head Neck Surg. 1994 Jul;111(1):31-7. doi: 10.1177/019459989411100108. Otolaryngol Head Neck Surg. 1994. PMID: 8028939 Clinical Trial.

9

Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer.

Pfister DG, Bajorin D, Motzer R, Scher H, Louison C, Harrison L, Shah J, Strong E, Bosl G. Pfister DG, et al. Arch Otolaryngol Head Neck Surg. 1994 Jan;120(1):89-95. doi: 10.1001/archotol.1994.01880250077011. Arch Otolaryngol Head Neck Surg. 1994. PMID: 8274261 Clinical Trial.

10

A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer.

Pfister DG, Bajorin D, Motzer RJ, Scher H, Louison C, Harrison L, Shah J, Strong E, Bosl G. Pfister DG, et al. Invest New Drugs. 1993 Feb;11(1):53-6. doi: 10.1007/BF00873911. Invest New Drugs. 1993. PMID: 8349436 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page